Activation of the TLRs pathway induces the translocation of NF-κB to the nucleus, where it promotes transcription of inflammation mediators, including IFN-γ, IL-6, and TNF-α, all of which are associated with cardiac hypertrophy [171]. The gene discussed is NFKB1; the disease is cardiac hypertrophy.